Featured Research

from universities, journals, and other organizations

Major Advance In Human Antibody Therapy Against Deadly Nipah Virus

Date:
October 31, 2009
Source:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Summary:
Scientists report a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

This is an artificially colored transmission electron micrograph of Hendra virus.
Credit: AAHL Australian Biosecurity Microscopy Facility

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

Nipah and Hendra viruses are found in Pteropid fruit bats (flying foxes) and are characterized by their recent emergence as agents capable of causing illness and death in domestic animals and humans.

In experiments carried out in ferrets at the Australian Animal Health Laboratory in Geelong, Victoria, Australia, where there is a high-level safety and security facility for working with live Nipah and Hendra viruses, the team of researchers demonstrated that giving an anti-virus human monoclonal antibody therapy after exposure to Nipah virus protected the animals from disease.

"These findings are extremely encouraging and clearly suggest the potential that a treatment for Hendra virus infection in a similar manner should be possible, given the very strong cross-reactive activity this antibody has against Hendra virus," said Deborah Middleton, D.V.M., Ph.D., who directed the animal experiments at the Australian Animal Health Laboratory.

Recent earlier work at the National Cancer Institute and USU resulted in the discovery and development of a human monoclonal antibody, m102.4, which could attack a critical component of both the Nipah and Hendra viruses. Antibodies -- proteins found in blood or other bodily fluids of vertebrates -- are used by the immune system to identify and neutralize viruses and bacteria.

The study's corresponding authors are Christopher C. Broder, Ph.D., professor of microbiology at USU, and Katharine Bossart, Ph.D., a USU alumna, now an assistant professor in the Department of Microbiology, Boston University School of Medicine and an investigator at the National Emerging Infectious Diseases Laboratories Institute in Boston. The pair led a team of researchers to test the effectiveness of the new antibody therapy in animals. The experiments were supported in part by the National Institute of Allergy and Infectious Diseases, NIH. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. provides research support and management capabilities to the research team.

"We now have good evidence that this antibody could save human lives and the insights offered about how it works also could potentially provide a starting point to developing tools for targeting other diseases," said study co-author Dimiter S. Dimitrov, Ph.D., senior biomedical research scientist at the National Cancer Institute.

Nipah and Hendra viruses, members of the henipavirus family, are highly infectious agents that emerged from flying foxes in the 1990s to cause serious disease outbreaks in humans and livestock in Australia, Bangladesh, India, Malaysia and Singapore. Recent outbreaks have resulted in acute respiratory distress syndrome and encephalitis, person-to-person transmission, and up to 75 percent case fatality rates among humans. Additionally, these properties could allow the viruses to be used as bioterror weapons.

Initial experiments by the researchers using ferrets found that m102.4 was well tolerated, exhibited no adverse effects and retained high neutralizing activity. The findings suggested that m102.4 could potentially be used as a preventive or post-exposure agent, a diagnostic probe or a research reagent.

Hendra virus re-emerged again in August 2009, resulting in the death of several horses and one human. During the outbreak, in a compassionate attempt to save a human life, an available low dose of m102.4 was administered to an individual with advanced encephalitic disease. Although there were no adverse side effects, the patient did not improve as the irreversible damage by the virus had already been done. Like other antimicrobials, the clinical success of this antibody will depend on dose and time of administration. As Hendra and Nipah viruses cause severe disease in humans, a successful application of this antibody as a post-exposure therapy will likely require early intervention.

"In order to make clinical use of this therapeutic antibody against Hendra or Nipah virus, larger amounts will need to be prepared under proper manufacturing guidelines, carefully evaluated again in animal models and safety tested for human use" said Dr. Broder.

Dr. Bossart noted, "We hope this demonstration of anti-viral activity will foster some immediate activities to facilitate further development for future use in humans."

"There are currently no licensed and approved vaccines or therapeutics for prevention and treatment of disease caused by these viruses for humans or livestock," said Dr. Broder. "This fully-human monoclonal antibody is the first antiviral agent against the Nipah and Hendra viruses that has a genuine potential for human therapeutic use."

"The generation of these antibodies as therapeutics could help control outbreaks in geographical regions susceptible to henipaviruses, and could turn information from a deadly pathogen into a benefit for mankind," said Dr. Dimitrov.


Story Source:

The above story is based on materials provided by Henry M. Jackson Foundation for the Advancement of Military Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bossart et al. A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection. PLoS Pathogens, 2009; 5 (10): e1000642 DOI: 10.1371/journal.ppat.1000642

Cite This Page:

Henry M. Jackson Foundation for the Advancement of Military Medicine. "Major Advance In Human Antibody Therapy Against Deadly Nipah Virus." ScienceDaily. ScienceDaily, 31 October 2009. <www.sciencedaily.com/releases/2009/10/091030125048.htm>.
Henry M. Jackson Foundation for the Advancement of Military Medicine. (2009, October 31). Major Advance In Human Antibody Therapy Against Deadly Nipah Virus. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2009/10/091030125048.htm
Henry M. Jackson Foundation for the Advancement of Military Medicine. "Major Advance In Human Antibody Therapy Against Deadly Nipah Virus." ScienceDaily. www.sciencedaily.com/releases/2009/10/091030125048.htm (accessed September 30, 2014).

Share This



More Plants & Animals News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

California University Designs Sustainable Winery

California University Designs Sustainable Winery

Reuters - US Online Video (Sep. 27, 2014) Amid California's worst drought in decades, scientists at UC Davis design a sustainable winery that includes a water recycling system. Vanessa Johnston reports. Video provided by Reuters
Powered by NewsLook.com
Argentina Worries Over Decline of Soybean Prices

Argentina Worries Over Decline of Soybean Prices

AFP (Sep. 27, 2014) The drop in price of soy on the international market is a cause for concern in Argentina, as soybean exports are a major source of income for Latin America's third largest economy. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Mama Bear, Cubs Hang out in California Backyard

Mama Bear, Cubs Hang out in California Backyard

Reuters - US Online Video (Sep. 27, 2014) A mama bear and her two cubs climb trees, wrestle and take naps in the backyard of a Monrovia, California home. Vanessa Johnston reports. Video provided by Reuters
Powered by NewsLook.com
'Crazy' Climate Forces Colombian Farmers to Adapt

'Crazy' Climate Forces Colombian Farmers to Adapt

AFP (Sep. 26, 2014) Once upon a time, farming was a blissfully low-tech business on Colombia's northern plains. Duration: 02:05 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins